These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35440929)

  • 1. Improvements for the Prior Authorization Process for Elective Surgical Procedures at an Academic Medical Center.
    Marble KY; Briggs GR; Gordy XZ
    Perspect Health Inf Manag; 2022; 19(1):1l. PubMed ID: 35440929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior authorization as a utilization management tool for elective superficial venous procedures results in high administrative cost and low efficacy in reducing utilization.
    Lee V; Berland T; Jacobowitz G; Rockman C; Sadek M; Barfield M; Cayne N; Maldonado TS
    J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):383-389.e1. PubMed ID: 31859243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a comprehensive medication prior-authorization service.
    Leinss R; Karpinski T; Patel B
    Am J Health Syst Pharm; 2015 Jan; 72(2):159-63. PubMed ID: 25550140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhouse authorization center to improve reimbursement for outpatient chemotherapy infusions.
    Desai SS
    Am J Health Syst Pharm; 2011 May; 68(9):828-34. PubMed ID: 21515867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice.
    Merrill JR; Flitcroft MA; Miller T; Beichner B; Clarke CN; Maduekwe UN; Wang TS; Dream S; Christians KK; Gamblin TC; Evans DB; Kothari AN
    J Surg Res; 2023 Aug; 288():269-274. PubMed ID: 37037166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative's Prior Authorization Learning Collaborative.
    Psotka MA; Singletary EA; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; McClellan MB; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006564. PubMed ID: 32683983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden with No Benefit: Prior Authorization in Congenital Cardiology.
    Marcus BS; Bansal N; Saef J; Fink C; Patel A; Shaffer KD; Mayer JE; Johnson JN; Shaffer K; Chowdhury D
    Pediatr Cardiol; 2024 Jan; 45(1):100-106. PubMed ID: 37750969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior authorization requirements in the office-based laboratory setting are administratively inefficient and threaten timeliness of care.
    Harish KB; Chervonski E; Speranza G; Maldonado TS; Garg K; Sadek M; Rockman CB; Jacobowitz GR; Berland TL
    J Vasc Surg; 2024 May; 79(5):1195-1203. PubMed ID: 38135169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Institutional Analysis of Insurance Denial Patterns Within Rhinology.
    Janz TA; Khan NS; Dhanda AK; Takashima M; Wu AW; Tang DM; Higgins TS; Ramanathan M; Ahmed OG
    Am J Rhinol Allergy; 2024 Jul; 38(4):218-222. PubMed ID: 38544439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a specialty medication prior-authorization service at an urban academic medical center.
    Martin MT; Telebak E; Taylor PA; Volozhina O
    Am J Health Syst Pharm; 2016 Aug; 73(15):1174-9. PubMed ID: 27440624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review.
    Popatia S; Flood KS; Golbari NM; Patel PV; Olbricht SM; Kimball AB; Porter ML
    J Am Acad Dermatol; 2019 Dec; 81(6):1308-1318. PubMed ID: 31103568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic Operational Redesign for Successfully Navigating Prior Authorization Barriers at a Large-Volume Proton Therapy Center.
    Brooks ED; Ning MS; Palmer MB; Gunn GB; Frank SJ; Shah AK
    JCO Oncol Pract; 2020 Oct; 16(10):e1067-e1077. PubMed ID: 32639929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Patient Experience of Prior Authorization for Cancer Care.
    Chino F; Baez A; Elkins IB; Aviki EM; Ghazal LV; Thom B
    JAMA Netw Open; 2023 Oct; 6(10):e2338182. PubMed ID: 37851442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proactive medical necessity review program reduces revenue loss associated with outpatient medical benefit drugs.
    Hawes EM; Misita CP; Amerine LB; Francart SJ
    Am J Health Syst Pharm; 2021 Aug; 78(17):1591-1599. PubMed ID: 33599737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insurance Denials and Patient Treatment in a Large Academic Radiation Oncology Center.
    Shin JY; Chino F; Cuaron JJ; Washington C; Jablonowski M; McBride S; Gomez DR
    JAMA Netw Open; 2024 Jun; 7(6):e2416359. PubMed ID: 38865128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care.
    Ning MS; Palmer MB; Shah AK; Chambers LC; Garlock LB; Melson BB; Frank SJ
    JCO Oncol Pract; 2020 Sep; 16(9):e966-e976. PubMed ID: 32302271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries.
    Mark TL; Parish WJ; Zarkin GA
    JAMA Netw Open; 2020 Apr; 3(4):e203132. PubMed ID: 32310285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating implementation outcomes (acceptability, adoption, and feasibility) of two initiatives to improve the medication prior authorization process.
    Jones LK; Ladd IG; Gregor C; Evans MA; Graham J; Gionfriddo MR
    BMC Health Serv Res; 2021 Nov; 21(1):1259. PubMed ID: 34801025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and implementation of a centralized comprehensive refill authorization program in an academic health system.
    Rim MH; Thomas KC; Hatch B; Kelly M; Tyler LS
    Am J Health Syst Pharm; 2018 Feb; 75(3):132-138. PubMed ID: 29371194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance Between Inflammatory Bowel Disease Specialists and Insurance Authorization Denials-A Survey of Specific Inflammatory Bowel Disease Treatment Scenarios.
    Naritsin A; Mehta N; Pellish R
    Crohns Colitis 360; 2024 Jan; 6(1):otad082. PubMed ID: 38264509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.